麻豆传媒

Critical Care >

Myocardial Infarction

News, opinions and meeting coverage in critical care.

TCT: Trials Split on PCI vs CABG for Left Main Disease

NOBLE hands advantage to surgery, EXCEL finds noninferiority

CardioBrief: Impella No Better Than IABP in Cardiogenic Shock

Underpowered IMPRESS trial shows no mortality benefit

ESC: DES or BMS? No Mortality Difference

After 6 years, death was as likely in DES patients as in BMS patients

EuroPCR: Staged Stenting Undermines SYNTAX II Strategy

Practice of unnecessary "re-touching" in the cath lab needs to go

Survival Rates Good With VAD for Complicated Acute MI

Despite being sicker to start, outcomes on par with other VAD patients

ACC: No Benefit for Beta-Blocker Before PCI

IV metoprolol was safe, but disappointing

CNN Calls Out 'Cataract Risk' in HOPE-3

Statins and cataracts: So what?

CardoBrief: The Vulnerable Plaque 'Hype-othesis'

A requiem for vulnerable plaque

Early Risk Period Seen for Survivors of Cardiogenic Shock

In-hospital mortality declining but a vulnerable time follows for rehospitalization, studies say

PA Home Visits Save $$ After Cardiac Surgery

Physician assistant house calls cut unnecessary post-op readmissions

Stent for MI Linked to Subsequent Surgery Risks

More evidence supporting waiting period for noncardiac surgery

FDA Lifts Restriction On Rosiglitazone

Agency sees no need for restrictions after easing them 2 years ago

CardioBrief: 'Walking Time Bombs'

Is this fear mongering or effective communication of risk?

Is SAMHSA to Blame for a Broken Mental Health System?

Two members of Congress differ on how to fix a failing system

Safety Warning: Watch LVAD Battery Expiration

Ventricular support backup battery issue linked to two deaths

Guidelines Issued for Managing Temperature During CBP

Clinicians now have officially sanctioned procedures to follow

Testosterone Shots: Riskier Than Gels or Patches?

Spike in T levels from bolus injections may explain higher adverse outcome rates.

TECOS Top Line: No Increase in CV Risk with DPP-4 Inhibitor

Primary and secondary endpoints met for those on sitagliptin.

ACC: Folate Supplements Cut Strokes in Hypertension

Hypertensive patients with low blood folate levels gain big benefit.

Morning Break: Penis Reduction? Patient Suffering

Health news and commentary from around the Web, gathered by the 麻豆传媒 staff.

CardioBuzz: Why Patients Don鈥檛 Take Heart Meds

Faced with patients' instinctive aversion to pills, even after MI, what's a cardiologist to do?

ESC: Will CvLPRIT Change Practice?

BARCELONA -- Cardiologists react to findings from the CvLPRIT study, which challenge not only traditional thinking but also existing guidelines from both the U.S. and Europe, all of which say that treating nonculprit arteries in STEMI patients may be harmful.

The Day My Brother Became a Statistic

My brother would have turned 37 today. Instead, he became a statistic in 1995.

CardioBuzz: Is Marijuana Bad for Your Heart?

Whether marijuana actually causes cardiovascular problems remains unclear, a situation that was not necessarily helped by a study based on 35 reports of cannabis-related complications in France, a country with about 1.2 million recreational users.

How To Get Medicare To Cover A Spa Trip

Good news for doctors who think their patients need a trip to the spa: Medicare will reimburse, with only two catches.

How to Replace IV Nitroglycerin in the Shortage

What are the alternatives for IV nitroglycerin in the emergency setting as the shortage saps reserves? Several experts share their thoughts.

ACC: Metformin No Help in MI Recovery

WASHINGTON -- Metformin started soon after reperfusion in the acute setting didn't help cardiac function recover in nondiabetic heart attack patients, a trial showed.

Top 5 Reasons Cardiologists Get Sued

Problems with diagnosis -- failing to make one, making the wrong one, or taking too long to get to one -- lead the list of reasons behind cardiology-related lawsuits, revealed closed claims data from a medical malpractice insurer.

Is There a Flaw in This Large Vitamin D Trial?

A co-principal investigator of the VITAL trial addresses the possibility that out-of-study testing of vitamin D levels and initiation of high-dose supplementation could be a limitation, but not a serious one.

Heart Attack Signal Found for Spiriva in COPD

The TIOSPIR trial was used to support safety of the mist inhaler version of tiotropium (Spiriva) compared with dry powder, but the pooled data actually showed something else -- a heart attack signal, researchers argued.

CardioBuzz: More Money Needed for Heart Research?

The NIH dedicates a lot of money for research into heart disease and stroke, but it still might not be enough, a new study suggested.

FDA Flags Risk of Nuclear Stress Test Drugs

SILVER SPRING, Md. -- Two agents used in cardiac nuclear stress tests may carry a greater risk of heart attack and death than previously believed, the FDA said Wednesday.

TCT: Removing Clot During PCI Fails in NSTEMI

SAN FRANCISCO -- Aspiration thrombectomy during percutaneous coronary intervention (PCI) did not improve outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI), a randomized trial showed.

Add 'Shrapnel' to Workup for Lightning Strike

A shrapnel-like injury associated with a lightening strike provided a reminder for emergency physicians not to overlook the unexpected when examining patients.

Lab Notes: Meth May Worsen Fungal Infection

Mice injected with methamphetamine and exposed to Cryptococcus fungi showed more extensive and hard-to-eradicate infections. Also this week: an organic pesticide fights parasitic worms.

Zilver Stent Recalled, System May Break

Cook Medical's Zilver PTX drug-eluting stent for peripheral artery disease has been recalled because of a defect in its associated delivery system, the company and the FDA said.

ACC: Is Chelation Plus Vitamins a Winning Combo?

SAN FRANCISCO -- Vitamins alone won't improve outcomes for patients who've had a heart attack, but they do appear to have additive benefits when given in conjunction with controversial chelation therapy, researchers reported here.

Extended Apixaban Stops VTE Recurrence

ATLANTA -- Apixaban taken for an additional year after standard venous thromboembolism (VTE) treatment reduced recurrent events in a placebo-controlled trial, researchers said.

Cardio Notes: Sex Improves with Stenting

Opening the arteries of those with stable coronary disease also opens the door to an improved sex life. Also this week, bariatric surgery helps remodel the heart.

Doctors Say 45 Common Tests 'Overused'

Nine specialty groups have listed tests and treatments that are frequently overused, such as antibiotics for sinus attacks and CT scans for low back pain, in the first phase of a long-term project.

鈥�

8